专栏名称: 解说科研项目
解说国自然,主要公益解说国家自然科学基金相关政策,提供医学科学部项目撰写策略、注意事项等;同时,还进行医学相关的课题设计、SCI论文撰写投稿、医学统计与meta分析、生物信息学等培训交流。为广大医生朋友们的科研和基金申请提供帮助!
目录
相关文章推荐
育学园  ·  一月确诊2328例!有娃刚开学就被放假10天 ... ·  4 小时前  
养育男孩  ·  这样批评孩子,真的会让他充满“羞耻感” ·  14 小时前  
养育男孩  ·  这样批评孩子,真的会让他充满“羞耻感” ·  14 小时前  
科学家庭育儿  ·  连续推荐3年,自带bra不尴尬的家居服,软糯更透气 ·  14 小时前  
科学家庭育儿  ·  户外装备一键升级!冲锋衣也能穿出高回头率!全 ... ·  14 小时前  
51好读  ›  专栏  ›  解说科研项目

SAGE期刊精选 | 25本优质开放获取期刊推荐

解说科研项目  · 公众号  ·  · 2019-09-10 11:28

正文

01

材料及工程


Advanced Composites Letters

该刊是经过同行评审的开放获取期刊,重点关注并出版自然科学和工程学领域先进复合材料或结构相关的研究论文。该刊 2018年影响因子相较2017年增长了32%。


Authors will enjoy:

  • Rigorous peer review of your research

  • Impact Factor: 0.556

  • Multidisciplinary audience

  • Open access format, driving high visibility and global exposure

  • Prompt online publication


期刊官网:https://journals.sagepub.com/home/acma



Advances in Mechanical Engineering

该刊是经过同行评审的开放获取期刊,面向机械工程各个领域出版原创学术论文以及综述文章,欢迎来自基础及应用研究领域的稿件并鼓励具有新颖和创新见解的投稿。 该刊2018年影响因子相较2017年增长21%。


Authors will enjoy:

  • Impact Factor: 1.024

  • A wide range of Special Collections

  • A prestigious international Editorial Board

  • An open access format ensures maximum visibility

  • Retention of copyright under a creative commons license


期刊官网:

https://journals.sagepub.com/home/ade



International Journal of Distributed Sensor Networks

该刊是经过同行评审的开放获取期刊,重点关注传感器网络的应用研究和应用实践。


Authors will enjoy:

  • Impact Factor : 1.614

  • A wide range of Special Collections

  • A prestigious international Editorial Board

  • An open access format for maximum visibility

  • Rapid online publication of your paper


期刊官网:

https://journals.sagepub.com/home/dsna



Journal of Engineered Fibers and Fabrics

该刊是经过同行评审的开放获取期刊,旨在促进纺织品、服装和纤维结构工程研究的快速和广泛传播。


Authors will enjoy:

  • Impact Factor: 0.474

  • Rigorous peer review of your research

  • Multidisciplinary audience

  • Open access format, driving high visibility and global exposure

  • Prompt online publication


期刊官网:

https://journals.sagepub.com/home/jefa


02

临床医学


Therapeutic Advances in Musculoskeletal Disease

该刊是经过同行评审的开放获取期刊,出版风湿病学、骨质疏松症以及相关学科各领域的前沿探索和创新研究。 该刊2018年影响因子相较2017年增长了46%。

Authors will enjoy:
  • Impact Factor: 5.045
  • Ranked 6 out of 31 in Rheumatology
  • Listed in PubMed and indexed in Web of Science, Science Citation Index Expanded (SCIE), Scopus and Directory of Open Access Journals (DOAJ)
  • Rigorous peer review
  • Rapid publication
  • Over 500,000 article views on PubMed Central in 2018


期刊主页:

https://journals.sagepub.com/home/taba




Journal of International Medical Research

该刊是经过同行评审的开放获取期刊,重点关注并出版原创的医学研究、临床前与临床研究成果,综述文章及初步和试验研究内容。 该刊 2018年影响因子相较2017年增长32%。


Authors will enjoy:

  • Impact Factor: 1.351

  • Ranked 112 out of 136 in Medicine, Research & Experimental


期刊官网:

https://journals.sagepub.com/home/imra



Therapeutic Advances in Endocrinology and Metabolism

该刊是经过同行评审的开放获取期刊,出版内分泌病学与代谢病学领域的前沿探索和创新研究。


Authors will enjoy:
  • Launched in 2010
  • Impact Factor: 3.543
  • Indexed in PubMed, PubMed Central, Scopus, SCIE
  • Rigorous peer review
  • Rapid publication
  • Over 540,000 article views on PubMed Central in 2018

期刊主页:

https://journals.sagepub.com/home/taea



Therapeutic Advances in Gastroenterology

该刊是经过同行评审的开放获取期刊,出版消化病学与肝脏病学领域的前沿探索和创新研究。


Authors will enjoy:
  • Impact Factor: 3.961
  • Ranked 25 out of 84 in Gastroenterology & Hepatology
  • Listed in PubMed and indexed in SCIE, Scopus and DOAJ
  • Rigorous peer review
  • Rapid publication
  • Over 1 million total article views on PubMed Central in 2018

期刊主页:

https://journals.sagepub.com/home/taga




Therapeutic Advances in Medical Oncology

该刊是经过同行评审的开放获取期刊,出版癌症药物治疗领域的前沿探索和创新研究。


Authors will enjoy:

  • Impact Factor: 5.670
  • Ranked 39 out of 229 in Oncology
  • Listed in PubMed, SCIE, PMC, Scopus and DOAJ
  • International expert Editorial Board and panel of Associate Editors
  • Rigorous and fast peer review
  • Rapid online publication (~3 weeks after article acceptance)

期刊主页:

https://journals.sagepub.com/home/tama




Clinical and Applied Thrombosis/Hemostasis

该刊 是经过同行评审的开放获取期刊,出版癌症药物治疗领域的前沿探索和创新研究。

Authors will enjoy:
  • Impact Factor: 1.846

  • Rigorous peer review of your research
  • Multidisciplinary audience
  • Open access format, driving high visibility and global exposure
  • Prompt online publication


期刊官网:

https://journals.sagepub.com/home/cata




SAGE Open Medicine

该刊是经过同行评审的开放获取期刊,出版涵盖医学领域广泛学科的研究成果,欢迎广义卫生科学领域的原创研究和综述文章投稿。该期刊已被 Pubmed Central 和 ESCI 收录。


Authors will enjoy:
  • Open access dissemination of your article, and indexing in PubMed
  • Publication in a journal that is indexed in ESCI
  • Authors retain copyright under a Creative Commons license
  • Reviewers get credit for their work via the journal's partnership with Publons


期刊主页:

https://journals.sagepub.com/home/smoa


03

健康与护理


Therapeutic Advances in Respiratory Disease

该刊是经过同行评审的开放获取期刊,出版呼吸系统疾病各个领域的前沿探索和创新研究。


Authors will enjoy:
  • Launched in 2007
  • Impact Factor: 3.286
  • Ranked 22 out of 63 in Respiratory System
  • Indexed in MEDLINE
  • Rigorous peer review
  • Rapid publication

期刊主页:

https://journals.sagepub.com/home/tara



American Journal of Men's Health

该刊 是经过同行评审的开放获取期刊,侧重于有关男性健康和疾病的前沿信息。该期刊隶属于 Men’s Health Network

Authors will enjoy:
  • Impact Factor: 1.409

  • Rigorous peer review of your research
  • Multidisciplinary audience
  • Open access format, driving high visibility and global exposure
  • Prompt online publication

期刊官网:

https://journals.sagepub.com/home/jmha



Therapeutic Advances in Chronic Disease

该刊是经过同行评审的开放获取期刊,出版慢性疾病药物治疗领域的高质量论文、综述文章和学术评论。旨在为临床和药理学领域的临床医生和研究人员提供一个发表高质量论文的平台,提供印刷和网络两个版本。


Authors will enjoy:

  • Impact Factor: 4.455
  • Indexed in PubMed, PubMed Central, SCIE, Medscape, SCOPUS and DOAJ
  • Gold open access journal – all articles are made freely available online immediately upon publication
  • Over 450,000 full article views on PubMed Central annually
  • Reaches a broad, interdisciplinary audience



期刊官网:
https://journals.sagepub.com/home/taja



Integrative Cancer Therapies

该刊 是经过同行评审的开放获取期刊,内容涵盖癌症综合治疗的广泛领域,重点关注对替代疗法和传统医学治疗的科学理解。


Authors will enjoy:

  • Impact Factor of 2.634
  • A journal that has been accepted into the SCIE, SCOPUS, MEDLINE, and is a member of COPE
  • Being published in the first journal to spearhead and focus on a new and growing movement in cancer treatment
  • A leading resource, presenting scientfically rigorous original research, case studies, and current literature reviews
  • An emphasis on scientific understanding of alternative medicine and traditional medicine therapies and their responsible integration with conventional health care

期刊官网:
https://journals.sagepub.com/home/icta


04

治疗进展


Therapeutic Advances in Hematology

该刊 是经过同行评审的开放获取期刊,关注临床与药理学相关内容,旨在为血液病学领域的临床医生和研究人员提供一个发表高质量论文的平台,提供印刷和网络两个版本。


Authors will enjoy:

  • Impact Factor: 3.105
  • Listed in PubMed and indexed in SCIE and Directory of DOAJ
  • Rigorous peer review
  • Rapid publication
  • Over 300,000 article views on PubMed Central in 2018
期刊主页:
https://journals.sagepub.com/home/taha



Therapeutic Advances in Psychopharmacology

该刊是经过同行评审的开放获取期刊,关注临床和药理学相关内容,旨在为精神药理学领域的临床医生和研究人员提供一个发表高质量学术论文的平台,提供印刷和网络两个版本。


Authors will enjoy:
  • Launched in 2011
  • Gold open access journal
  • Listed in PubMed and indexed in SCIE and DOAJ
  • Impact Factor: 3.000
  • Rapid publishing – OnlineFirst publication usually within 3 weeks of acceptance
  • Published in association with the British Association for Psychopharmacology
  • 800,000 full article views annually


期刊主页:

https://journals.sagepub.com/home/tppa





Therapeutic Advances in Neurological Disorders

该刊是经过同行评审的开放获取期刊,出版神经科学各个领域的前沿探索和创新研究。

Authors will enjoy:
  • Launched in 2008
  • Impact Factor: 3.580
  • Listed in PubMed and indexed in SCIE, Scopus and DOAJ
  • A leading gold open access journal in Clinical Neurology
  • Average time from submission to first decision is 36 days
  • Rapid online publication
  • Over 1 million full article views annually


期刊主页:

https://journals.sagepub.com/home/tana


05

肿瘤、生命与生物医学


Evolutionary Bioinformatics

该刊是经过同行评审的国际性开放获取期刊,专注于进化生物信息学。旨在通过使用分子、遗传、基因组和蛋白质组学数据并充分考虑其进化背景,促进读者对生物形式和功能的理解。 该刊2018年影响因子相较2017年增长17%。


Authors will enjoy:

  • Impact Factor:







请到「今天看啥」查看全文